Humana Inc. vs Abbvie Inc.
HUM vs ABBV — side-by-side comparison from reported financials. HUM leads 7, ABBV leads 5 of 12 comparable metrics.
Humana Inc.
HUM · Healthcare
$438.49+13.27%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | HUM | ABBV |
|---|---|---|
| Price | $438.49 | $276.43 |
| Market cap | $52.6B | $488B |
| Revenue (TTM) | $146B | $64.4B |
| Revenue growth | +11.8% | +1.8% |
| Net margin | 0.9% | 9.8% |
| Free cash flow | $1.95B | $18.2B |
| Net cash (debt) | $7.53B | ($56.2B) |
| 1-year price return | +50.9% | +19.8% |
| P/E | 40.5 | 77.4 |
| P/E vs own history (cheap-side %) | 0% | 23% |
| Dividend yield | 0.83% | 2.45% |
| Return on equity | 7% | 96% |
| Altman Z-score | 2.34 | 2.33 |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 67,060 | 57,000 |
Full résumé-style profiles: HUM CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.